metopimazine

This page covers all metopimazine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting D(2) dopamine receptor, D(3) dopamine receptor, Histamine H1 receptor.

Targets

D(2) dopamine receptor, D(3) dopamine receptor, Histamine H1 receptor

Phase 2 pipeline (1)

• Vogalene · Other
  Metopimazine works by blocking the D(2) dopamine receptor, which can help regulate various physiological processes.

Patent intelligence

• metopimazine patent landscape — aggregated cliff calendar, attackable patents, originator estates